NDC 72611-785

Temsirolimus

Temsirolimus Injection

Temsirolimus is a Kit in the Human Prescription Drug category. It is labeled and distributed by Almaject, Inc.. The primary component is .

Product ID72611-785_34ec5220-ae2c-b43b-6e8c-95f007b70474
NDC72611-785
Product TypeHuman Prescription Drug
Proprietary NameTemsirolimus
Generic NameTemsirolimus Injection
Dosage FormKit
Marketing Start Date2020-05-08
Marketing CategoryANDA / ANDA
Application NumberANDA207383
Labeler NameAlmaject, Inc.
Active Ingredient Strength0
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 72611-785-02

1 KIT in 1 CARTON (72611-785-02) * 1 mL in 1 VIAL, SINGLE-DOSE (72611-780-01) * 1.8 mL in 1 VIAL, SINGLE-DOSE (72611-782-01)
Marketing Start Date2020-05-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72611-785-02 [72611078502]

Temsirolimus KIT
Marketing CategoryANDA
Application NumberANDA207383
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-05-08

Drug Details

NDC Crossover Matching brand name "Temsirolimus" or generic name "Temsirolimus Injection"

NDCBrand NameGeneric Name
16729-223Temsirolimustemsirolimus
65219-200TemsirolimusTemsirolimus
68083-202TemsirolimusTemsirolimus Injection
72611-785TemsirolimusTemsirolimus Injection
0008-1179Toriseltemsirolimus
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.